Ferozsons Laboratories products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Public listed pharmaceutical company · Lahore · Pakistan
Pakistan-listed pharmaceutical company founded in 1954 with local manufacturing, specialty medicines, international partnerships and medical-technology operations.
Ferozsons Laboratories products in Pakistan
Ferozsons Laboratories Limited has 86 medicine presentations registered in Pakistan under 35 brands, covering 31 generic medicines. Most of its products are in Anti-infectives, Endocrine & metabolic and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Empagen (Empagliflozin), Acylex (Aciclovir), Hexana (Chlorhexidine) and Apreon (Aprepitant). 86 products have an official DRAP price on MedInfoBase. See all 35 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Public listed pharmaceutical company
- Address
- 5 KM Sundar Raiwind Road, Raiwind, Lahore, Pakistan
- Website
- ferozsons-labs.com ↗
- Phone
- +92 42 36026700
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Ferozsons Laboratories Limited is priced against the market
71 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Acylex | Aciclovir | 200 mg/5 mL | Suspension | 60ml | 012684 | PKR 1,246.85 | PKR 20.78/mL | 🔒 Pharma Pro |
| Acylex | Aciclovir | 200 mg | Tablet | 5x5's | 012685 | PKR 2,066.36 | PKR 82.65/tablet | 🔒 Pharma Pro |
| Acylex | Aciclovir | 5 % | Ointment | 5gm (Tube) | 012686 | PKR 288.44 | PKR 57.69/g | 🔒 Pharma Pro |
| Acylex | Aciclovir | 400 mg | Tablet | 2x10's | 025586 | PKR 1,053.95 | PKR 52.70/tablet | 🔒 Pharma Pro |
| Acylex | Aciclovir | 800 mg | Tablet | 1x10's | 029021 | PKR 764.15 | PKR 76.42/tablet | 🔒 Pharma Pro |
| Acylex | Aciclovir | 5% | Cream | 5gm (Tube) | 114353 | PKR 175.56 | PKR 35.11/g | 🔒 Pharma Pro |
| Acylex w/w | Aciclovir | 5 % | Cream | 10gm (Tube) | 114353 | PKR 351.12 | PKR 35.11/g | 🔒 Pharma Pro |
| Apreon | Aprepitant | 40 mg | Capsule | 2's | 068201 | PKR 1,455.66 | PKR 727.83/capsule | 🔒 Pharma Pro |
| Apreon | Aprepitant | 80 mg | Capsule | 2's | 068202 | PKR 2,521.14 | PKR 1,260.57/capsule | 🔒 Pharma Pro |
| Apreon | Aprepitant | 125 mg | Capsule | 2's | 068203 | PKR 3,796.72 | PKR 1,898.36/capsule | 🔒 Pharma Pro |
| Apreon | Aprepitant | 80 mg | Capsule | 3's1's + 2's | 068204 | PKR 6,238.09 | — | No comparator |
| Apxan Tablet 2.5mgRegistry verified | Apixaban | — | — | — | 114311Official source ↗ | No indexed price | — | — |
| Apxan Tablet 5mgRegistry verified | Apixaban | — | — | — | 114312Official source ↗ | No indexed price | — | — |
| Aurora Tablets 10mgRegistry verified | Rosuvastatin | — | — | — | 046872Official source ↗ | No indexed price | — | — |
| Aurora Tablets 20mgRegistry verified | Rosuvastatin | — | — | — | 046871Official source ↗ | No indexed price | — | — |
| Avitop 10mg TabletRegistry verified | Rosuvastatin | — | — | — | 003376-EXOfficial source ↗ | No indexed price | — | — |
| Avitop 20mg TabletRegistry verified | Rosuvastatin | — | — | — | 003375-EXOfficial source ↗ | No indexed price | — | — |
| Azobar | Azithromycin | 500 mg | Tablet | 6's | 104216 | PKR 412.68 | PKR 68.78/tablet | 🔒 Pharma Pro |
| Azobar | Azithromycin | 250 mg | Tablet | 6's | 104217 | PKR 225.10 | PKR 37.52/tablet | 🔒 Pharma Pro |
| Azobar | Azithromycin | 200 mg/5 mL | Dry suspension | 30ml | 104218 | PKR 485.32 | PKR 16.18/mL | 🔒 Pharma Pro |
| Azobar | Azithromycin | 200 mg/5 mL | Dry suspension | 15ml | 104218 | PKR 247.62 | PKR 16.51/mL | 🔒 Pharma Pro |
| Azofer 250mg TabletRegistry verified | Azithromycin | — | — | — | 008860-EXOfficial source ↗ | No indexed price | — | — |
| Azofer 500mg TabletRegistry verified | Azithromycin | — | — | — | 008861-EXOfficial source ↗ | No indexed price | — | — |
| BENZYL BENZOATE APPLICATIONSRegistry verified | BENZYL BENZOATE 25%, W/V | — | — | — | 001504Official source ↗ | No indexed price | — | — |
| Bisonorm | Bisoprolol fumarate | 2.5 mg | Tablet | 1x14's | 127859 | PKR 37.34 | PKR 2.67/tablet | 🔒 Pharma Pro |
| Bisonorm | Bisoprolol fumarate | 5 mg | Tablet | 2x10's | 127860 | PKR 155.59 | PKR 7.78/tablet | 🔒 Pharma Pro |
| Bisonorm | Bisoprolol fumarate | 10 mg | Tablet | 2x10's | 127861 | PKR 280.06 | PKR 14.00/tablet | 🔒 Pharma Pro |
| Centaurus | Entecavir | 0.5 mg | Tablet | 3x10's | 052841 | PKR 20,345.53 | PKR 678.18/tablet | 🔒 Pharma Pro |
| Chlorvid | Hydroxychloroquine | 200 mg | Tablet | 3x10's | 101265 | PKR 405.18 | PKR 13.51/tablet | 🔒 Pharma Pro |
| Clarion | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 002872 | PKR 531.85 | PKR 8.86/mL | 🔒 Pharma Pro |
| Clarion | Clarithromycin | 500 mg | Tablet | 10's | 002873 | PKR 1,156.02 | PKR 115.60/tablet | 🔒 Pharma Pro |
| Clarion | Clarithromycin | 250 mg | Tablet | 10's | 018022 | PKR 665.42 | PKR 66.54/tablet | 🔒 Pharma Pro |
| Clarion | Clarithromycin | 500 mg | Extended-release tablet | 5's (1x5's) | 068466 | PKR 446.81 | — | No comparator |
| Clopid | Clopidogrel | 75 mg | Tablet | 2x10's | 036236 | PKR 540.85 | PKR 27.04/tablet | 🔒 Pharma Pro |
| Clopid | Clopidogrel | 75 mg | Tablet | 1x10's | 036236 | PKR 293.14 | PKR 29.31/tablet | 🔒 Pharma Pro |
| Dabiclo | Dabigatran etexilate | 75 mg | Capsule | 3x10's | 112836 | PKR 2,904.55 | PKR 96.82/capsule | 🔒 Pharma Pro |
| Dabiclo | Dabigatran etexilate | 150 mg | Capsule | 3x10's | 112837 | PKR 3,564.68 | PKR 118.82/capsule | 🔒 Pharma Pro |
| Daklana | Daclatasvir | 30 mg | Tablet | 28's | 085239 | PKR 5,401.15 | PKR 192.90/tablet | 🔒 Pharma Pro |
| Daklana | Daclatasvir | 60 mg | Tablet | 28's | 085240 | PKR 9,079.70 | PKR 324.28/tablet | 🔒 Pharma Pro |
| Diabetron | Gliclazide | 80 mg | Tablet | 20's | 016060 | PKR 238.94 | PKR 11.95/tablet | 🔒 Pharma Pro |
| Diabetron | Gliclazide | 90 mg | Tablet | 3x10's | 070312 | PKR 999.86 | PKR 33.33/tablet | No comparator |
| Diabetron | Gliclazide | 60 mg | Tablet | 3x10's | 070313 | PKR 660.10 | PKR 22.00/tablet | 🔒 Pharma Pro |
| Diabetron | Gliclazide | 30 mg | Tablet | 3x10's | 070314 | PKR 398.00 | PKR 13.27/tablet | 🔒 Pharma Pro |
| Diclofen 50mg Enteric Coated TabletsRegistry verified | Diclofenac Sodium | — | — | — | 012415Official source ↗ | No indexed price | — | — |
| Empagen | Empagliflozin | 10 mg | Tablet | 7's | 103099 | PKR 499.98 | PKR 71.43/tablet | 🔒 Pharma Pro |
| Empagen | Empagliflozin | 10 mg | Tablet | 10's | 103099 | PKR 713.82 | PKR 71.38/tablet | 🔒 Pharma Pro |
| Empagen | Empagliflozin | 10 mg | Tablet | 14's | 103099 | PKR 999.96 | PKR 71.43/tablet | 🔒 Pharma Pro |
| Empagen | Empagliflozin | 10 mg | Tablet | 28's | 103099 | PKR 1,959.91 | PKR 70.00/tablet | 🔒 Pharma Pro |
| Empagen | Empagliflozin | 10 mg | Tablet | 30's | 103099 | PKR 2,099.91 | PKR 70.00/tablet | 🔒 Pharma Pro |
| Empagen | Empagliflozin | 25 mg | Tablet | 7's | 103100 | PKR 598.43 | PKR 85.49/tablet | 🔒 Pharma Pro |
All 35 Ferozsons Laboratories brands in Pakistan
- Acylex Aciclovir · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- Acylex w/w Aciclovir · 5 % cream
- Apreon Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- Azobar Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Bisonorm Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Centaurus Entecavir · 0.5 mg tablet
- Chlorvid Hydroxychloroquine · 200 mg tablet
- Clarion Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Clopid Clopidogrel · 75 mg tablet
- Dabiclo Dabigatran etexilate · 150 mg capsule, 75 mg capsule
- Daklana Daclatasvir · 30 mg tablet, 60 mg tablet
- Diabetron Gliclazide · 30 mg tablet, 60 mg tablet, 80 mg tablet
- Empagen Empagliflozin · 10 mg tablet, 25 mg tablet
- Epclusa Sofosbuvir + Velpatasvir · 100 mg + 400 mg tablet
- Ferolyte Dry Sodium chloride · 2.6 g sachet
- Harvoni Ledipasvir + Sofosbuvir · 90 mg + 400 mg tablet
- Hexana Chlorhexidine · 4% gel
- Icon Itraconazole · 100 mg capsule
- Lamify Terbinafine · 1 % cream
- Ledisa Ledipasvir + Sofosbuvir · 90 mg + 400 mg tablet
- Levo Levofloxacin · 250 mg tablet, 500 mg tablet
- Lormax Loratadine · 10 mg tablet
- Omega Omeprazole · 20 mg capsule, 40 mg capsule
- Phenobarbitone Phenobarbital · 30 mg tablet
- Proflox Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Quench Silver sulfadiazine · 1 % cream, 1% cream
- Salazodine-EC Sulfasalazine · 500 mg tablet
- Savera Sofosbuvir · 400 mg tablet
- Viktana Sofosbuvir · 100 mg tablet
- Viread Tenofovir disoproxil · 300 mg tablet
- Vorif Voriconazole · 200 mg tablet, 50 mg tablet
- Xavor Losartan · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Ximeva Cefixime · 400 mg capsule
- Ximeva DS Cefixime · 200 mg/5 mL suspension
- Xolox Ribavirin · 400 mg tablet, 500 mg tablet, 600 mg tablet
Ferozsons Laboratories: common questions
How many products does Ferozsons Laboratories have in Pakistan?
Ferozsons Laboratories Limited has 86 registered medicine presentations in Pakistan, sold under 35 brands and covering 31 generic medicines.
What are the main brands of Ferozsons Laboratories?
By number of registered strengths and packs, its largest brands are Empagen (Empagliflozin), Acylex (Aciclovir), Hexana (Chlorhexidine), Apreon (Aprepitant) and Azobar (Azithromycin). This is not a sales ranking.
Which therapy areas does Ferozsons Laboratories cover?
The most products are in Anti-infectives (51), Endocrine & metabolic (14), Gastrointestinal & hepatology (7), Cardiovascular (7) and Hematology & thrombosis (4).
Where can I see Ferozsons Laboratories medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.